These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant. Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533 [TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324 [TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. Ahmed K; Rao S; Simha V Endocr Pract; 2010; 16(3):449-51. PubMed ID: 20061292 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between methimazole and antineutrophil cytoplasmic antibody-positive vasculitis]. Chen LQ; Zhang XL; Wu HY; Guo S; Li XZ Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):446-9. PubMed ID: 19099784 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan. Huang CN; Hsu TC; Chou HH; Tsay GJ J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822 [TBL] [Abstract][Full Text] [Related]
7. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967 [TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China. Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466 [TBL] [Abstract][Full Text] [Related]
10. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU). Kubota S Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole. Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217 [TBL] [Abstract][Full Text] [Related]
12. Methimazole-induced antineutrophil cytoplasmic antibody-associated diffuse alveolar haemorrhage in a Chinese woman with Graves' disease. Lau EY; So SY; Chan E; Kwok J; Ma J; Kung AW Hong Kong Med J; 2009 Jun; 15(3):209-12. PubMed ID: 19494377 [TBL] [Abstract][Full Text] [Related]
13. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312 [TBL] [Abstract][Full Text] [Related]
14. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil. Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368 [TBL] [Abstract][Full Text] [Related]
16. Case report: Propylthiouracil-induced serious side effect: Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis or IgA vasculitis? Zhang W; Liu X; Wang X; Ma H; Zhang P Medicine (Baltimore); 2024 Jul; 103(27):e38790. PubMed ID: 38968474 [TBL] [Abstract][Full Text] [Related]
17. Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Thong HY; Chu CY; Chiu HC Acta Derm Venereol; 2002; 82(3):206-8. PubMed ID: 12353714 [No Abstract] [Full Text] [Related]
18. Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole. Bilu Martin D; Deng A; Gaspari A; Pearson F Skinmed; 2006; 5(6):302-5. PubMed ID: 17086001 [TBL] [Abstract][Full Text] [Related]
19. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Gao Y; Zhao MH; Guo XH; Xin G; Gao Y; Wang HY Endocr Res; 2004 May; 30(2):205-13. PubMed ID: 15473130 [TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody. Criado PR; Grizzo Peres Martins AC; Gaviolli CF; Alavi A Int J Low Extrem Wounds; 2015 Jun; 14(2):187-91. PubMed ID: 25256279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]